- call +1-201-465-4211
- email sales@mrinsights.biz
Pompe disease is a rare disease, also known as acid maltase deficiency (AMD) or glycogen storage disorder (GSD).Glycogenosis II is also called "glycogenosis type 2".
Scope of the Report:
This report focuses on the Pompe Disease Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The availability of reimbursement policies for the treatment Pompe disease as one of the primary factors that will have a positive impact on the growth of this market.
The worldwide market for Pompe Disease Treatment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Amicus Therapeutics
Audentes Therapeutics
Sanofi Genzyme
EpiVax
Oxyrane
Sangamo BioSciences
Valerion Therapeutics
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Infantile-Onset Pompe Disease
Adult-Onset Pompe Disease
Market Segment by Applications, can be divided into
Hospital
Medical Center
Other
There are 15 Chapters to deeply display the global Pompe Disease Treatment market.
Chapter 1, to describe Pompe Disease Treatment Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Pompe Disease Treatment, with sales, revenue, and price of Pompe Disease Treatment, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Pompe Disease Treatment, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Pompe Disease Treatment market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Pompe Disease Treatment sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Pompe Disease Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Infantile-Onset Pompe Disease
1.2.2 Adult-Onset Pompe Disease
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Medical Center
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Amicus Therapeutics
2.1.1 Business Overview
2.1.2 Pompe Disease Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Amicus Therapeutics Pompe Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Audentes Therapeutics
2.2.1 Business Overview
2.2.2 Pompe Disease Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Audentes Therapeutics Pompe Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Sanofi Genzyme
2.3.1 Business Overview
2.3.2 Pompe Disease Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Sanofi Genzyme Pompe Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 EpiVax
2.4.1 Business Overview
2.4.2 Pompe Disease Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 EpiVax Pompe Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Oxyrane
2.5.1 Business Overview
2.5.2 Pompe Disease Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Oxyrane Pompe Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Sangamo BioSciences
2.6.1 Business Overview
2.6.2 Pompe Disease Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sangamo BioSciences Pompe Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Valerion Therapeutics
2.7.1 Business Overview
2.7.2 Pompe Disease Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Valerion Therapeutics Pompe Disease Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Pompe Disease Treatment Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Pompe Disease Treatment Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Pompe Disease Treatment Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Pompe Disease Treatment Manufacturer Market Share in 2017
3.3.2 Top 6 Pompe Disease Treatment Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Pompe Disease Treatment Market Analysis by Regions
4.1 Global Pompe Disease Treatment Sales, Revenue and Market Share by Regions
4.1.1 Global Pompe Disease Treatment Sales and Market Share by Regions (2013-2018)
4.1.2 Global Pompe Disease Treatment Revenue and Market Share by Regions (2013-2018)
4.2 North America Pompe Disease Treatment Sales and Growth Rate (2013-2018)
4.3 Europe Pompe Disease Treatment Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Pompe Disease Treatment Sales and Growth Rate (2013-2018)
4.5 South America Pompe Disease Treatment Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Pompe Disease Treatment Sales and Growth Rate (2013-2018)
5 North America Pompe Disease Treatment by Countries
5.1 North America Pompe Disease Treatment Sales, Revenue and Market Share by Countries
5.1.1 North America Pompe Disease Treatment Sales and Market Share by Countries (2013-2018)
5.1.2 North America Pompe Disease Treatment Revenue and Market Share by Countries (2013-2018)
5.2 United States Pompe Disease Treatment Sales and Growth Rate (2013-2018)
5.3 Canada Pompe Disease Treatment Sales and Growth Rate (2013-2018)
5.4 Mexico Pompe Disease Treatment Sales and Growth Rate (2013-2018)
6 Europe Pompe Disease Treatment by Countries
6.1 Europe Pompe Disease Treatment Sales, Revenue and Market Share by Countries
6.1.1 Europe Pompe Disease Treatment Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Pompe Disease Treatment Revenue and Market Share by Countries (2013-2018)
6.2 Germany Pompe Disease Treatment Sales and Growth Rate (2013-2018)
6.3 UK Pompe Disease Treatment Sales and Growth Rate (2013-2018)
6.4 France Pompe Disease Treatment Sales and Growth Rate (2013-2018)
6.5 Russia Pompe Disease Treatment Sales and Growth Rate (2013-2018)
6.6 Italy Pompe Disease Treatment Sales and Growth Rate (2013-2018)
7 Asia-Pacific Pompe Disease Treatment by Countries
7.1 Asia-Pacific Pompe Disease Treatment Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Pompe Disease Treatment Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Pompe Disease Treatment Revenue and Market Share by Countries (2013-2018)
7.2 China Pompe Disease Treatment Sales and Growth Rate (2013-2018)
7.3 Japan Pompe Disease Treatment Sales and Growth Rate (2013-2018)
7.4 Korea Pompe Disease Treatment Sales and Growth Rate (2013-2018)
7.5 India Pompe Disease Treatment Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Pompe Disease Treatment Sales and Growth Rate (2013-2018)
8 South America Pompe Disease Treatment by Countries
8.1 South America Pompe Disease Treatment Sales, Revenue and Market Share by Countries
8.1.1 South America Pompe Disease Treatment Sales and Market Share by Countries (2013-2018)
8.1.2 South America Pompe Disease Treatment Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Pompe Disease Treatment Sales and Growth Rate (2013-2018)
8.3 Argentina Pompe Disease Treatment Sales and Growth Rate (2013-2018)
8.4 Colombia Pompe Disease Treatment Sales and Growth Rate (2013-2018)
9 Middle East and Africa Pompe Disease Treatment by Countries
9.1 Middle East and Africa Pompe Disease Treatment Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Pompe Disease Treatment Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Pompe Disease Treatment Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Pompe Disease Treatment Sales and Growth Rate (2013-2018)
9.3 UAE Pompe Disease Treatment Sales and Growth Rate (2013-2018)
9.4 Egypt Pompe Disease Treatment Sales and Growth Rate (2013-2018)
9.5 Nigeria Pompe Disease Treatment Sales and Growth Rate (2013-2018)
9.6 South Africa Pompe Disease Treatment Sales and Growth Rate (2013-2018)
10 Global Pompe Disease Treatment Market Segment by Type
10.1 Global Pompe Disease Treatment Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Pompe Disease Treatment Sales and Market Share by Type (2013-2018)
10.1.2 Global Pompe Disease Treatment Revenue and Market Share by Type (2013-2018)
10.2 Infantile-Onset Pompe Disease Sales Growth and Price
10.2.1 Global Infantile-Onset Pompe Disease Sales Growth (2013-2018)
10.2.2 Global Infantile-Onset Pompe Disease Price (2013-2018)
10.3 Adult-Onset Pompe Disease Sales Growth and Price
10.3.1 Global Adult-Onset Pompe Disease Sales Growth (2013-2018)
10.3.2 Global Adult-Onset Pompe Disease Price (2013-2018)
11 Global Pompe Disease Treatment Market Segment by Application
11.1 Global Pompe Disease Treatment Sales Market Share by Application (2013-2018)
11.2 Hospital Sales Growth (2013-2018)
11.3 Medical Center Sales Growth (2013-2018)
11.4 Other Sales Growth (2013-2018)
12 Pompe Disease Treatment Market Forecast (2018-2023)
12.1 Global Pompe Disease Treatment Sales, Revenue and Growth Rate (2018-2023)
12.2 Pompe Disease Treatment Market Forecast by Regions (2018-2023)
12.2.1 North America Pompe Disease Treatment Market Forecast (2018-2023)
12.2.2 Europe Pompe Disease Treatment Market Forecast (2018-2023)
12.2.3 Asia-Pacific Pompe Disease Treatment Market Forecast (2018-2023)
12.2.4 South America Pompe Disease Treatment Market Forecast (2018-2023)
12.2.5 Middle East and Africa Pompe Disease Treatment Market Forecast (2018-2023)
12.3 Pompe Disease Treatment Market Forecast by Type (2018-2023)
12.3.1 Global Pompe Disease Treatment Sales Forecast by Type (2018-2023)
12.3.2 Global Pompe Disease Treatment Market Share Forecast by Type (2018-2023)
12.4 Pompe Disease Treatment Market Forecast by Application (2018-2023)
12.4.1 Global Pompe Disease Treatment Sales Forecast by Application (2018-2023)
12.4.2 Global Pompe Disease Treatment Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Pompe Disease Treatment Picture
Table Product Specifications of Pompe Disease Treatment
Figure Global Sales Market Share of Pompe Disease Treatment by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
